FDA Releases Draft Guidance on Labeling for Human Prescription Drugs and Biological Products

Summary

The US Food and Drug Administration (FDA) has released a draft guidance to help pharmaceutical companies write clear and consistent labeling for human prescription drugs and biological products. The guidance aims to ensure that labeling is clear, concise, and informative, and is consistent within and across different drug classes.